NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CellType

CellType

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.celltype.com/

Last Round

Seed

Jan 1, 2026

Total Funding Raised

$500,000

Company Overview

CellType is a life sciences and artificial intelligence company that has developed a biological reasoning engine to simulate drug responses in human biology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

drug discoverybiological foundation modelsin silico drug discoveryagentic drug discoverybiological world modelAI biotechvirtual human simulationcomputational biologysingle-cell gene expressionpreclinical drug developmentAI drug discoverypredictive toxicologybiotech SaaSprecision medicineAI agent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellType Comparables

Compare CellType with similar companies based on industry and business-model similarity.

CellType comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenBio AI
87%
Helical
86%
Noetik
86%

CellType Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2026

CellType Investors

Notable investors and investment history

CellType investors
InvestorRounds
Pioneer FundSeed
Y CombinatorSeed

CellType Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CellType Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellType's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range4
Year Founded2025
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.